When blood cancer in children progresses particularly aggressively, it is often due to a genetic defect: a gene fusion, such as the NUP98 fusion oncoprotein, which drives uncontrolled cell growth.
Time from medication order to administration of cabazitaxel (C) vs. lutetium Lu-177 vipivotide tetraxetan (Lu) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). This is ...
FACS-based whole-genome CRISPRi screen to uncover STEAP1 regulators in prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results